A research team led by Prof. Bai Shuo from the Institute of Process Engineering of the Chinese Academy of Sciences has pioneered a fully biodegradable, self-powered implantable electrical stimulation system designed to enhance muscle repair.
Coffee may do more than boost energy. New research suggests that certain compounds found in roasted coffee beans could help slow how quickly sugar enters the bloodstream, a finding that could one day support new foods aimed at managing type 2 diabetes.
DiaCardia, a novel artificial intelligence model that can accurately identify individuals with prediabetes using either 12-lead or single-lead electrocardiogram (ECG) data, has been developed. This breakthrough holds promise for future home-based prediabetes screening using consumer wearable devices, without requiring invasive blood tests.
Researchers develop an innovative dural patch that achieves rapid, watertight sealing of dural tears, boasting high biocompatibility
Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations with a high degree of accuracy.
Researchers have developed a wearable, comfortable and washable device called Revoice that could help people regain the ability to communicate naturally and fluently following a stroke, without the need for invasive brain implants.
New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI computational models that predict the degeneration of neural networks in amyotrophic lateral sclerosis (ALS).
Retinal vein occlusion (RVO) is a severe disease that occurs when a vein in the light-sensitive layer at the back of the eye (i.e., the retina) becomes blocked, which results in a loss of vision. There are currently a few medical interventions that address RVO, including the periodic injection of medications that block the abnormal growth of blood vessels or of steroids, which reduce swelling and inflammation.
A team of Mass General Brigham researchers has developed one of the first fully autonomous artificial intelligence (AI) systems capable of screening for cognitive impairment using routine clinical documentation.
Amplifi Vascular announced that it received breakthrough device designation for its Amplifi Vein Dilation System.